Inventor · Bosch en Duin, NL

Marc van Dijk

43Patents
5h-index
37Co-inventors
61Inventor score

Filing activity: May 28, 2015 → Jun 23, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US10280226B2 Anti-GITR antibodies and methods of use thereof Emerging Cross-Sectional Technologies 14 Active
US10155818B2 Anti-GITR antibodies and methods of use thereof Emerging Cross-Sectional Technologies 14 Active
US10259882B2 Anti-OX40 antibodies Physics 11 Active
US10639368B2 Anti-TIM-3 antibodies and methods of use thereof Chemistry; Metallurgy 10 Active
US10836830B2 Antibodies and methods of use thereof Chemistry; Metallurgy 9 Active
US10626181B2 Nucleic acids encoding anti-OX40 antibodies Physics 5 Active
US10144779B2 Anti-CTLA-4 antibodies and methods of use thereof Chemistry; Metallurgy 5 Active
US10912831B1 Anti-CTLA-4 antibodies and methods of use thereof Emerging Cross-Sectional Technologies 4 Active
US10479833B2 Anti-CTLA-4 antibodies and methods of use thereof Chemistry; Metallurgy 4 Active
US11013802B2 Anti-CTLA-4 antibodies and methods of use thereof Emerging Cross-Sectional Technologies 3 Active
US10577426B2 Anti-GITR antibodies and methods of use thereof Emerging Cross-Sectional Technologies 3 Active
US10323091B2 Anti-PD-1 antibodies and methods of use thereof Chemistry; Metallurgy 3 Active
US10844119B2 Anti-LAG-3 antibodies and methods of use thereof Chemistry; Metallurgy 2 Active
US10675348B2 Antibodies that bind human C6 and uses thereof Chemistry; Metallurgy 2 Active
US10912828B2 Anti-TIM-3 antibodies and methods of use thereof Chemistry; Metallurgy 2 Active
US10882908B2 Anti-LAG-3 antibodies and methods of use thereof Chemistry; Metallurgy 2 Active
US10800849B2 Anti-GITR antibodies and methods of use thereof Emerging Cross-Sectional Technologies 2 Active
US11638755B2 Anti-CTLA-4 antibodies and methods of use thereof Emerging Cross-Sectional Technologies 1 Active
US10829559B2 Anti-GITR antibodies and methods of use thereof Physics 1 Active
US11345755B2 Anti-PD-1 antibodies and methods of use thereof Chemistry; Metallurgy 1 Active
US11718658B2 T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof Chemistry; Metallurgy 1 Active
US11267889B2 Anti-CTLA-4 antibodies and methods of use thereof Chemistry; Metallurgy 0 Active
US12391741B2 T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof Chemistry; Metallurgy 0 Active
US11098117B2 Anti-CD137 antibodies and methods of use thereof Chemistry; Metallurgy 0 Active
US12187795B2 Anti-LAG-3 antibodies and methods of use thereof Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.